Local drug therapy for preventing restenosis after angioplasty has been investigated for over a decade. Biologically active agents ranging from drugs to genes can be delivered locally using a wide variety of catheters. Microspheres, liposomes, and polymers have been used to enhance drug retention at the delivery site. More recently stents have been investigated as devices to attain local drug delivery, either by coating with polymers, seeding with genetically modified cells or by using them as a source of local radiation. Though the best method of delivering agents locally remains undefined, this approach is likely to emerge as an essential mode of therapy in the near future.
Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: An alternative proposal for cellular mechanisms. J Am Coll Cardiol20:1284, 1992
2.
Forrester JS, Fishbein M, Helfant R, Fagin J. A paradigm for restenosis based on cell biology: Clues for the development of new preventive therapies. J Am Coll Cardiol17:758, 1991
3.
Kovach JA, Mintz GS, Kent KM, Pichard AD, Satler LF, Popma JJ. Leon MB. Serial intnvascular ultrasound studies indicate that chronic recoil is an important mechanism of restenosis following transcatheter therapy. J Am Coll Cardiol21:484A, 1993
4.
Kakuta T, Currier JW, Haudenschild CC, Ryan TJ. Faxon DP. Differences in compensatory vessel enlargement, not intimal formation, account for restenosis after angioplasty in the hypercholesterolemic rabbit model. Circulation89:2809, 1994
5.
Post MJ. Borst C, Kuntz RE.The relative importance of arterial remodeling compared with intimal hyperplasia in lumen renarrowing after balloon angioplasty. Circulation89:2816, 1991
6.
Goldman B, Blanke H, Wolinsky H. Influence of pressure on permeability of normal and diseased muscular arteries to horseradish peroxidase. Atherosclerosis65:215, 1987
7.
Wolinsky H. Thung SN.Use of a perforated balloon catheter to deliver concentrated heparin into the wall of the normal canine artery. J Am Coll Cardiol15:475, 1990
8.
Lambert CR, Leone JE, Rowland SM. Local drug delivery catheters: functional comparison of porous and micro-porous designs. Cor Art Dis4:469, 1993
9.
Strauss BH, Wilson RA, van Houten R, et al. Late effects of locally delivered mitomycin C on formation of neointima and on vasomotor response to acetycholine. Cor Art Dis23:633, 1991
10.
Thomas CN, Robinson KE, Cipolla GD, Jones M, King SB III, Scott NA. In vivo local delivery of heparin to coronary arteries with a microporous infusion catheter. J Am Coll Cardiol23:187A, 1991
11.
Hong MK, Farb A, Unger EF; Wang JC, Jasinski LJ, Mehlman MD. A new PTCA balloon catheter with intramural channels for local delivery of drugs at low pressure. Circulation86:1-380, 1992
12.
Hong MK, Bhatti T, Matthews BJ, et al. The effect of porous infusion balloon-delivered angiopeptin on myointimal hyperplasia after balloon injury in the rabbit. Circulation88:3638, 1993
13.
Feldman LJ, Steg PG, Zheng LP, Barry JJ, Perricaudet M, Isner JM.Efficient percutaneous adenovirus-mediated arterial gene transfer using a channelled angioplasty balloon catheter. Circulation90:1-20, 1993
14.
Hebert D, Lam JYT, Moura A, Kaplan AV.Local intramural nitroglycerin delivery improves vascular responses to balloon arterial injury. J Am Coll Cardiol25:286A, 1995
15.
Kaplan AV, Vandormael M, Bartorelli A, Hofmann M, Stoerger H, Simpson JB, Reifart N.Heparin delivery at the site of angioplasty with a novel drug delivery sleeve: Initial clinical series. J Am Coll Cardiol25:286A, 1995
16.
Camenzind E, Reys A, Ligthart J, Bakker W, van Geijlswijk I, Fioretti P, Krenning E, Serruys PW. Local intra-coronary delivery of heparin and of a somatostatin analogue (octreotide) following angioplasty in man: Evaluation of efficacy of delivery by radioisotopic technique. J Am Coll Cardiol25:285A, 1995
17.
McKay RG, Fram DB, Hirst JA, et al. Treatment of intra-coronary thrombus with local urokinase infusion using a new, site-specific drug delivery system: The Dispatch catheter. Catheter Cardiovasc Diag33:181, 1994
18.
Mitchel JF, Azrin MA, Fram DB, et al. Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydro-gel balloons. Circulation90:1979, 1991
19.
Willard JE, Landay C, Glamann DB, et al. Genetic modification of the vessel wall: Comparison of surgical and catheter-based techniques for delivery of recombinant adenovirus. Circulation89:2190, 1991
20.
Fram DB, Aretz T, Azrin MA, et al. Localized intramural drug delivery during balloon angioplasty using hydrogel-coated balloons and pressure-augmented diffusion. J Am Coll Cardiol23:1570, 1994
21.
Nunes GL, Hanson SR, King SB 3rd, Sahatjian RA, Scott NA. Local delivery of a synthetic antithrombin with a hydrogel-coated angioplasty balloon catheter inhibits platelet dependent thrombosis. J Am Coll Cardiol23:1578, 1994
22.
Azrin MA, Mitchel JF, Fram DB, et al. Decreased platelet deposition and smooth muscle cell proliferation after intramural heparin delivery with hydrogel-coated balloons. Circulation90:433, 1994
23.
Riessen R, Rahimizadeh H, Blessing E, Takeshita S, Barry JJ, Isner JM. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum Gene Ther4:749, 1993
24.
Mitchel JF, Azrin MA, Fram DB, Schwedick MW, Alberghini T, Waters DD, McKay RG. Intramural deposition of urokinase at the angioplasty site: Comparative efficiency of systemic and local drug delivery techniques. Circulation4:97, 1990
25.
Theiss U, Kuhn I, Lucker PW. Iontophoresis: Is there a future for clinical application?Methods Find Exp Clin Pharmacol13:353, 1991
26.
Soria I, Hassinger NL, Owen WG, Chesebro JH. Local delivery of hirudin into rabbit carotid arteries with an iontophoretic balloon catheter. Circulation88:3552, 1993
27.
Femandez-Ortiz A, Meyer BJ, Mailhac A, et al. A new approach for local intravascular drug delivery: Iontophoretic balloon. Circulation89:1518, 1994
28.
Mitchel JF, Azrin MA, Fram DB, et al. Localized intracoronary delivery of heparin with iontophoresis. J Am Coll Cardiol25:285 A, 1995
29.
Hanson SR, Harker LA. Interruption of acute platelet-dependent thrombosis by the synthetic antithrombin D-phenylalanyl-L-prolyl-L-arginyl chloromethylketone. Proc Natl Acad Sci USA85:3184, 1988
30.
Hanson SR, Wilcox JN, Kelly AB, Lumsden AB, Scott NA, Harker LA. Thrombin mediation of arterial smooth muscle cell proliferation after mechanical injury in nonhuman primates. Blood80:166A, 1992
31.
Simons M, Edelman ER, DeKeyser JL, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature359:67, 1992
32.
Morishita R, Gibbons GH, Ellison KE, et al. Single intra-luminal delivery of antisense cdc-2 kinase and proliferating cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA90:23474, 1993
33.
Simons M, Rosenberg RD. Antisense nonmuscle myosin heavy chain and c-myb oligonucleotides suppress smooth muscle cell proliferation in vitro. Circ Res70:2335, 1992
34.
Morishita R, Gibbons GH, Ellison KE, et al. Single intra-luminal delivery of antisense cdc-2 kinase and proliferating cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Nat Acad Sci USA90:23474, 1993
35.
Simons M, Edelman ER, Dekeyser JL, Langer R, Rosenberg RD. Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature359:67, 1992
36.
Simons M, Edelman ER, Rosenberg RD. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. J Clin Invest93:2351, 1991
37.
Spears JR, Yellayi SS, Makkar R, et al. Effects of thermal exposure on binding of heparin in vitro to the arterial wall and to clot and on the chronic angiographic luminal response to local application of a heparin film during angioplasty in an in vivo rabbit model. Lasers Surg Med14:329, 1993
38.
Felgenr PL, Gadek TR, Holm M, et al. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc Natl Acad Sci USA84:7413, 1987
Nabel EG, Plautz G, Nabel GJ. Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science249:1285, 1990
41.
Lim CS, Chapman GD, Gammon RS. et al. Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog. Circulation83:2007, 1991
42.
Poiani GJ, Wilson FJ, Fox JD, et al. Liposome-entrapped antifibrotic agent prevents collagen accumulation in hypertensive pulmonary arteries of rats. Circ Res70:912, 1992
43.
March KL, Mohanraj S, Ho PP, Wilensky RL, Hathaway DR. Biodegradable microspheres containing a colchicine analogue inhibit DNA synthesis in vascular smooth muscle cells. Circulation89:1929, 1991
44.
Wilensky RL, March KL, Hathaway DR. Direct intra-arte-rial wall injection of microparticles via a catheter: A potential drug delivery strategy following angioplasty. Am Heart J122:1136, 1991
45.
Dev V, Zeng H, Forrester JS, et al. Microspheres for drug delivery to the arterial wall: A study of kinetics. toxicity and effects of corticosteroid loaded microspheres. J Am Coll Cardiol23:19A, 1991
46.
Dev V, Zeng H, Forrester J, et al. Biodegradable micro-spheres for sustained drug delivery to the arterial wall. Circulation88:I, 1993
47.
Pastore C, Feldman LJ, Perricaudet M, Steg PG. Intraluminal delivery of a phonic gel enhances adenovirus-mediated arterial gene transfer: A morphometric study. Circulation90:I-517, 1993
48.
Taguchi J, Abe J, Okazaki H, Ochiai M, Ohno M, Takuwa Y, Kurokawa K. Angiotensin converting enzyme inhibitors or DuP753 prevent neointimal formation following balloon injury with single topical or multiple systemic application. Biochem Biophys Res Com196:969, 1993
49.
Abe J, Zhou W, Taguchi J, et al. Suppression of neointimal smooth muscle cell accumulation in vivo by antisense ***cdc-2 and cdk-2 oligonucleotides in rat carotid artery. Biochem Biophys Res Com198:16, 1991
50.
Edelman ER. Adams DH, Karnovsky MJ.Effect of controlled adventitial heparin delivery on smooth muscle proliferation following endothelial injury. Proc Natl Acad Sci USA87:3773, 1990
51.
Lambert TL, Dev V, Rechavia E, Forrester JS, Litvack F, Eigler NL. Localized arterial wall drug delivery from a polymer-coated removable metallic stent: Kinetics, distribution, and bioactivity of forskolin. Circulation90:1003, 1991
52.
De Scheerder I, Wilczek KL, Van Dorpe J, et al. Angiopeptin loaded stents inhibit the neointimal reaction induced by polymer coated stents implanted in porcine coronary arteries. J Am Coll Cardiol25:286A, 1995
53.
Muller DW, Golomb G, Gordon D, Levy RJ. Site-specific dexamethasone delivery for the prevention of neointimal thickening after vascular stent implantation. Cor Art Dis5:435, 1991
54.
Villa AE, Guzman LA, Chen WV, Golomb G, Levy RJ, Topol EJ. Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty. J Clin Invest93:1243, 1991
55.
De Scheerder, Wilczek K, Verbeken E. et al. Amphihiphilic polyurethane coating of intracoronary stents decreases mortality due to subacute thrombosis in a porcine coronary model. JACC1A, 1991
56.
Sheth S, Park KD, Dev V, et al. Prevention of stent subacute thrombosis by segmented polyurethaneurea-polyethylene oxide-heparin coating in the rabbit carotid. J Am Coll Cardiol23:891, 1991
57.
Bailey SR, Paige S, Lunn A, Palmaz J. Heparin coating of endovascular stents decreases subacute thrombosis in a rabbit model. Circulation86:I-186, 1992
58.
Rogers C, Karnovsky MJ, Edelman ER.Inhibition of experimental neointimal hyperplasia and thrombosis depends on the type of vascular injury and the site of drug administration. Circulation88:1215, 1993
59.
Lincoff AM, Furst JG, Ellis SG, Topol El. Sustained local drug delivery by a novel intravascular eluting stent to prevent restenosis in the porcine coronary artery. J Am Coll Cardiol23:18A, 1993
60.
Khorsandi MJ, Eigler NL, Lambert T. et al. Temporary stenting with the heat activated recoverable temporary stent. Implantations up to six weeks (Abstr). Circulation86:I-800, 1992
61.
Mahrer KN, Eigler NL, Khorsandi MJ, Fishbein MC, Forrester JS, Kupfer J, Litvack F.Development of the heat activated recoverable temporary stent (HARTS) with a slotted-tube design for coronary application. J Am Coll Cardiol23:484A, 1994
62.
Dev D, Eigler N, Sheth S, Lambert T, Forrester J, Litvack F. Kinetics of drug delivery to the arterial wall via polyurethane-coated removable nitinol stent: Comparative study of two drugs. Catheter Cardiovasc Diag34:272, 1995
63.
Murphy JG, Schwartz RS, Huber KC, Holmes DR. Polymeric stents: Modem alchemy or the future. J Inyasive Cardiol3:144, 1991
64.
Zidar JP, Lincoff AM, Stack RS. Biodegradable stents. In Topol El (ed). Textbook of interventional cardiology (2nd ed.) W.E. Saunders, Philadelphia, pp. 787-802, 1993
65.
Murphy JG. Schwartz RS. Edwards WD, Camrud AR, Vliestra RE, Homes DR.Percutaneous polymeric stents in porcine coronary arteries: Initial experience with polyethylene terephthalae stents. Circulation86:1596, 1992
66.
Lincoff AM, van der Giessen WJ, Schwartz RS, et al. Biodegradable and biostable polymers may both cause vigorous inflammatory responses when implanted in the porcine coronary artery. J Am Coll Cardiol21:179A, 1993
67.
Zidar JP, Gammon RS, Chapman GD, et al. Short and longterm vascular tissue response to the Duke bioabsorbable stent. J Am Coll Cardiol21:439A, 1993
68.
Dichek DA, Neville RF, Zwiebel JA, Freeman SM, Leon MB, Anderson WF. Seeding of intravascular stents with genetically engineered endothelial cells. Circulation80:1347, 1989
69.
Flugelman MY, Virmani R, Leon MB, et al. Genetically engineered endothelial cells remain adherent and viable after stent deployment and exposure to flow in vitro. Circ Res70:348, 1992
70.
Eskin SG, Meidell RS, McNatt J, et al. Protective effect of mutant tissue plasminogen activator expressed from endothelial cells seeded on implanted stents. Circulation841-589, 1991
71.
Kipshidze N, Baker JE, Nikolaychik V. Fibrin coated stents as an improved vehicle for endothelial cell seeding. Circulation90:3218A, 1994
72.
Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB III. Long-term efficacy and safety of endovascular low dose irradiation in a swine model of restenosis after angioplasty. J Am Coll Cardiol25:287A, 1995
73.
Waksman R, Robinson KA, Crocker IR, Gravanis MB, Cipolla GD, King SB III. Endovascular low-dose irradiation inhibits neointima formation after coronary artery balloon injury in swine. Circulation91:1533, 1995
74.
Wedermann JG, Marboe C, Schwartz A, Amols H, Weinberger J.Intracoronary irradiation markedly reduces restenosis after balloon angioplasty in a porcine model. Circulation88:1-655, 1993
75.
Hehrlein C, Donges K, Gollan C, Metz J, Fehsenfeld P. Low-dose radioactive Palmaz-Schatz stents prevent smooth muscle cell proliferation and neointimal hyperplasia in rabbits. J Am Coll Cardiol25:9A, 1995
76.
Laird JR, Carter AJ, Kufs WM, Hoopes TG, Farb A, Nott S, Fischell RE, Fischell DR, Virmani R, Fischell TA.Inhibition of neointimal proliferation with a beta particle emitting stent. J Am Coll Cardiol25:287A, 1995
77.
Epstein SE, Speir E, Finkel T.Do antisense approaches to the problem of restenosis make sense?Circulation88:1351, 1993
78.
Condado JA, Gurdiel O, Espinoza R, Brito JG, Harrison ML, Joyner LR, Liprie SF. Percutaneous transluminal coronary angioplasty (PTCA) and intracoronay radiation therapy (ICRT): A possible new modality for the treatment of coronary restenosis. A preliminary report of the first 10 patients treated with intracoronary radiation therapy. J Am Coll Cardiol25:288A, 1995
79.
Macus-Sekura CJ. Techniques for using antisense oligodeoxynucleotides to study gene expression. Analyt Biochem172:289, 1988
80.
Akhhtar S, Juliano RL. Cellular uptake and intracellular fate of antisense oligonucleotides. Trends Cell Biol2:139, 1992
81.
Nicolou C, Sene C. Liposome-mediated DNA tnnsfer in eukaryotic cells: Dependence of transfer efficiency upon the type of liposome used and host cell cycle stage. Biochem Biophys Acta721:185, 1982
82.
Wagner EL, Zatloukal K, Cotten M, et al. Coupling of adenovirus to transferrin-polylysine/DNA complexes greatly enhances receptor-mediated gene delivery and expression of transfected genes. Proc Natl Acad Sci USA89:6099, 1992
83.
Yang NS, Burkholder J, Roberts B, et al. In vivo and in vitro gene transfer to mammalian somatic cells by particle bombardment. Proc Natl Acad Sci USA87:9568, 1990
84.
Neumann E, Schaefer-Ridder M, Wang Y, et al. Gene tnnsfer into mouse lyoma cells by electropolation in high electric fields. Embo J1:841, 1982
85.
Wolff JA, Malone RW, Williams P, et al. Direct gene transfer into mouse cells in vivo. Science247:1465, 1990
